06/01/2026
Approximately 36,000 to 60,000 people in the U.S. are living with Myasthenia Gravis, with nearly 1,000 new cases diagnosed each year. MG is a rare, chronic neuromuscular disorder that causes muscle weakness and fatigue — and it's often misunderstood.
Early diagnosis and infusion treatment options such as Imaavy, Rystiggo, Soliris, Ultomiris, Vyvgart, and Vyvgart Hytrulo have made a significant impact on the lives of MG patients by helping improve strength, mobility, and quality of life.
🧮 Calculate your treatment cost here: https://sageinfusion.com/
➡️ Refer a patient: https://sageinfusion.com/SubmitOrder/
Let’s support those living with MG by spreading awareness, advocating for research, and celebrating the progress made. 💪